Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis

[1]  Camille Stephan-Otto Attolini,et al.  Targeting metastasis-initiating cells through the fatty acid receptor CD36 , 2016, Nature.

[2]  E. Lengyel,et al.  Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube. , 2016, Cancer discovery.

[3]  T. Iwakuma,et al.  p53 as a Regulator of Lipid Metabolism in Cancer , 2016, International journal of molecular sciences.

[4]  M. Mann,et al.  Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status , 2016, Nature Communications.

[5]  A. Jemal,et al.  Cancer treatment and survivorship statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[6]  K. Gravdal,et al.  Development of a prosaposin-derived therapeutic cyclic peptide that targets ovarian cancer via the tumor microenvironment , 2016, Science Translational Medicine.

[7]  Jian-Dong Jiang,et al.  CD36 is a co-receptor for hepatitis C virus E1 protein attachment , 2016, Scientific Reports.

[8]  C. Thompson,et al.  The Emerging Hallmarks of Cancer Metabolism. , 2016, Cell metabolism.

[9]  Matthew N. Metzinger,et al.  Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages. , 2015, Cancer research.

[10]  V. Beral,et al.  Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer , 2015, Nature Reviews Cancer.

[11]  L. Roberts,et al.  Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma , 2015, Scientific Reports.

[12]  E. Lerma,et al.  Intratumor cholesteryl ester accumulation is associated with human breast cancer proliferation and aggressive potential: a molecular and clinicopathological study , 2015, BMC Cancer.

[13]  E. Lengyel,et al.  Molecular Pathways: Trafficking of Metabolic Resources in the Tumor Microenvironment , 2015, Clinical Cancer Research.

[14]  R. Tomasini,et al.  Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma , 2015, Proceedings of the National Academy of Sciences.

[15]  J. George,et al.  Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion. , 2014, The Journal of clinical investigation.

[16]  R. Eckel,et al.  Regulation of AMPK Activation by CD36 Links Fatty Acid Uptake to β-Oxidation , 2014, Diabetes.

[17]  O. Kuda,et al.  Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolism. , 2014, Annual review of nutrition.

[18]  E. Levy,et al.  Scavenger receptor CD36 mediates inhibition of cholesterol synthesis via activation of the PPARγ/PGC‐1α pathway and Insig1/2 expression in hepatocytes , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  E. Lengyel,et al.  Adipose tissue and adipocytes support tumorigenesis and metastasis. , 2013, Biochimica et biophysica acta.

[20]  E. White,et al.  Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids , 2013, Proceedings of the National Academy of Sciences.

[21]  Claudio R. Santos,et al.  Lipid metabolism in cancer , 2012, The FEBS journal.

[22]  A. Stahl,et al.  Fatty acid transport proteins, implications in physiology and disease. , 2012, Biochimica et biophysica acta.

[23]  G. Mithieux,et al.  Link between Intestinal CD36 Ligand Binding and Satiety Induced by a High Protein Diet in Mice , 2012, PloS one.

[24]  G. Mills,et al.  Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth , 2011, Nature Medicine.

[25]  H. Im,et al.  Targeting the Urokinase Plasminogen Activator Receptor Inhibits Ovarian Cancer Metastasis , 2010, Clinical Cancer Research.

[26]  S. Reddy,et al.  CD36 participates in a signaling pathway that regulates ROS formation in murine VSMCs. , 2010, The Journal of clinical investigation.

[27]  E. Lengyel.  Ovarian cancer development and metastasis. , 2010, The American journal of pathology.

[28]  D. Bernlohr,et al.  Fatty acid flux in adipocytes: The in's and out's of fat cell lipid trafficking , 2010, Molecular and Cellular Endocrinology.

[29]  T. Eggerman,et al.  CD36 Is a Novel Serum Amyloid A (SAA) Receptor Mediating SAA Binding and SAA-induced Signaling in Human and Rodent Cells* , 2010, The Journal of Biological Chemistry.

[30]  Chun Yang,et al.  Hypoxia Up-regulates CD36 Expression and Function via Hypoxia-inducible Factor-1- and Phosphatidylinositol 3-Kinase-dependent Mechanisms* , 2009, The Journal of Biological Chemistry.

[31]  H. Beer,et al.  Caspase-8 for Outer Harmony , 2009, Science Signaling.

[32]  U. Neumann,et al.  Intra‐abdominal tumor dissemination pattern and surgical outcome in 214 patients with primary ovarian cancer , 2009, Journal of surgical oncology.

[33]  R. Silverstein,et al.  CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior , 2009, Science Signaling.

[34]  P. Neufer,et al.  Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. , 2009, The Journal of clinical investigation.

[35]  X. Su,et al.  Cellular fatty acid uptake: a pathway under construction , 2009, Trends in Endocrinology & Metabolism.

[36]  R. Tothill,et al.  Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome , 2008, Clinical Cancer Research.

[37]  J. Viola,et al.  Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin-E2 synthesis in colon cancer cells. , 2008, Cancer research.

[38]  M. Miyazaki,et al.  Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart. , 2008, American journal of physiology. Endocrinology and metabolism.

[39]  E. Lengyel,et al.  Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra‐cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum , 2007, International journal of cancer.

[40]  G. Stark,et al.  Signal Transducer and Activator of Transcription 1 Is Required for Optimal Foam Cell Formation and Atherosclerotic Lesion Development , 2007, Circulation.

[41]  R. Agarwal,et al.  Mechanisms of transcoelomic metastasis in ovarian cancer. , 2006, The Lancet. Oncology.

[42]  W. Stremmel,et al.  Translocation of long chain fatty acids across the plasma membrane – lipid rafts and fatty acid transport proteins , 2006, Molecular and Cellular Biochemistry.

[43]  K. Esser,et al.  FoxO1 Stimulates Fatty Acid Uptake and Oxidation in Muscle Cells through CD36-dependent and -independent Mechanisms* , 2005, Journal of Biological Chemistry.

[44]  C. Iadecola,et al.  The Class B Scavenger Receptor CD36 Mediates Free Radical Production and Tissue Injury in Cerebral Ischemia , 2005, The Journal of Neuroscience.

[45]  S. Henderson,et al.  Predicting biomarkers for ovarian cancer using gene-expression microarrays , 2004, British Journal of Cancer.

[46]  L. Bonewald,et al.  Composition of the Extracellular Matrix of the Peritoneum , 2001, The Journal of the Society for Gynecologic Investigation: JSGI.

[47]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[48]  K. Matsumoto,et al.  Reduced adhesion of monocyte-derived macrophages from CD36-deficient patients to type I collagen. , 2001, Biochemical and biophysical research communications.

[49]  R. Silverstein,et al.  Defective Uptake and Utilization of Long Chain Fatty Acids in Muscle and Adipose Tissues of CD36 Knockout Mice* , 2000, The Journal of Biological Chemistry.

[50]  K. Matsumoto,et al.  Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[51]  M. Connelly,et al.  Lipid transporters: membrane transport systems for cholesterol and fatty acids. , 2000, Current opinion in clinical nutrition and metabolic care.

[52]  N. Abumrad,et al.  Binding of sulfosuccinimidyl fatty acids to adipocyte membrane proteins: Isolation and ammo-terminal sequence of an 88-kD protein implicated in transport of long-chain fatty acids , 1993, The Journal of Membrane Biology.

[53]  N. Tandon,et al.  Isolation and characterization of platelet glycoprotein IV (CD36). , 1989, The Journal of biological chemistry.

[54]  J. Barnwell,et al.  Isolation of the thrombospondin membrane receptor. , 1987, The Journal of clinical investigation.

[55]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[56]  E. Lengyel,et al.  Adipose tissue and adipocytes supports tumorigenesis and metastasis , 2013 .

[57]  Michael J Morgan,et al.  Crosstalk of reactive oxygen species and NF-κB signaling , 2011, Cell Research.

[58]  J. Heemskerk,et al.  CD36 as a multiple-ligand signaling receptor in atherothrombosis. , 2011, Cardiovascular & hematological agents in medicinal chemistry.

[59]  T. Barrette,et al.  ONCOMINE: a cancer microarray database and integrated data-mining platform. , 2004, Neoplasia.

[60]  J. Berman,et al.  CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils. , 2002, The American journal of pathology.